TIMH
IDXX icon

Tilt Investment Management Holdings’s Idexx Laboratories IDXX Stock Holding History

Tilt Investment Management Holdings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-442
Closed -$222K – 139
2023
Q2 		$222K Hold
442
– – 0.15% 139
2023
Q1 		$216K Buy
+442
New +$212K 0.16% 141

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Tilt Investment Management Holdings's IDXX Position: Q3 2023 in Review

Tilt Investment Management Holdings sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 442 shares — an estimated $222K sold.

Tilt Investment Management Holdings first reported a position in IDXX in Q1 2023 and held it in 2 quarters. The position peaked at $222K in Q2 2023. 1,060 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Tilt Investment Management Holdings reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Tilt Investment Management Holdings sold 442 Idexx Laboratories shares in Q3 2023, an estimated $222K.
  • Tilt Investment Management Holdings first reported a position in Idexx Laboratories in Q1 2023 and held it in 2 quarters.
  • Tilt Investment Management Holdings's Idexx Laboratories position peaked at $222K in Q2 2023.
  • 1,060 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.